Fasiglifam (TAK-875), a G Protein-Coupled Receptor 40 (GPR40) Agonist, May Induce Hepatotoxicity through Reactive Oxygen Species Generation in a GPR40-Dependent Manner

Fasiglifam (TAK-875) a G-protein coupled receptor 40 (GPR40) agonist, significantly improves hyperglycemia without hypoglycemia and weight gain, the major side effects of conventional anti-diabetics. Unfortunately, during multi-center Phase 3 clinical trials, unexpected liver toxicity resulted in pr...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Biomol Ther (Seoul)
Главные авторы: Kim, MinJeong, Gu, Gyo Jeong, Koh, Yun-Sook, Lee, Su-Hyun, Na, Yi Rang, Seok, Seung Hyeok, Lim, Kyung-Min
Формат: Artigo
Язык:Inglês
Опубликовано: The Korean Society of Applied Pharmacology 2018
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6254646/
https://ncbi.nlm.nih.gov/pubmed/29429148
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4062/biomolther.2017.225
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы